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Toxicity and Residue Studies in Dairy
Animals with FireMaster FF-1
(Polybrominated Biphenyls)
bv M. G. Robl,*t D. H. Jenkins,* R. J. Wingender,*
and D. E. Gordon*
Two studies (one in Holstein calves and one in Holstein cows) were conducted to determine potential
toxicity and residue levels following oral ingestion of polybrominated biphenyls (PBB). The material was
FireMaster FF-1. Administration was by gelatin capsules. Doses in calves were 0.1, 1.0, 10, or 100 mg/kg
body weight, while doses in cows were equivalent to 0.01, 0.1, 1.0, or 1C ppm in the diet.
The calves were sacrificed after 2, 4, 6, or 12 weeks. The cows were fed 158 or 228 days, and were then
in a recovery period for 182 or 112 days.
In the calfstudy, signs of toxicity were observed only in animals fed 100 mg/kg-day. Administration of
10 mg/kg-day or less for up to 12 weeks caused no overt signs oftoxicity. Histologic studies were conducted
upon selected organs and tissues taken at time of sacrifice. The only treatment-induced lesions among
animals fed 0.1 mg/kg-day were minimal lesions in the kidney and skin in the one calffed at this level for
12 weeks. Treatment-induced lesions were present in the kidneys, skin, and/or liver from some animals
fed levels of 1.0 mg/kg-day and above. The relative severity of these lesions was related to the level and
length of exposure. Treatment-associated changes were observed in the testes of all males in this study.
The hypospermatogenesis observed was consistent with the age ofthe animals due to prepuberal develop-
ment ofthe testes. No clinical signs oftoxicity or histologic changes attributed to PBB were observed in the
cows. Two cows were pregnant at the initiation of the study and give birth to normal, healthy calves
during the study. These calves grew normally and appeared healthy when sacrificed at about 6 months of
age.
Residue levels were quantitated as the hexabromobiphenyl isomer (BP-6) which is the major isomer
present in the PBB mixture. Tissue residue levels in calves increased with dose and duration of adminis-
tration ofPBB with highest levels being found in the fat. At 100 mg/kg the levels in fat were about 6000 to
6300 ppm after 6 to 12 weeks.
Residue levels ofBP-6 in milk and fat ofthe cows also increased with dose and duration ofadministra-
tion. Maximum levels in milk were about 1/3 the levels in the diet. In general, the levels plateaued after
about 4 to 6 weeks and did not go appreciably higher even though administration of the FireMaster FF-1
was continued. Maximum levels in fat were on the order ofapproximately 4.5 times the levels in the diet,
except at the lowest dose level.
Residues decreased in milk after administration of PBB was discontinued, but detectable levels were
still present 6 months later. Residues were found in the calves born of treated cows indicating passage of
the PBBs through the placental barrier and/or ingestion through the milk.
Introduction
Toxicity attributed to polybrominated biphenyls
which accidentally contaminated feed ofdairy cattle
was described by Jackson and Halbert (1). There-
fore, the two studies reported here were initiated.
The primary purpose of these studies was to study
possible toxicity and residue levels following oral
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administration of known doses of the material.
Since these studies were conducted, a study of tox-
icosis from polybrominated biphenyls in heifers has
been reported by Moorhead et al. (2).
One of the studies was conducted to evaluate the
potential toxic effects and to determine tissue res-
idues following oral adminis;ration to Holstein
calves. The other study was conducted to evaluate
potential toxicity and to determine residue levels in
milk, urine, feces and tissues following oral admin-
istration to mature Holstein cows.
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The polybrominated biphenyls were fed as Fire-
Master FF-1, which is a pulverized form of Fire-
Master PB-6 with 2% calcium trisilicate added to
prevent caking.
FireMaster BP-6 is a mixture of brominated
biphenyls with about 65% hexabromobiphenyls,
14% heptabromobiphenyls, 11% pentabromo-
biphenyls, and about 10o other biphenyls. Chemi-
cal analyses were for BP-6.
Methods
Calves
There were eight male and eight female Holstein
calves, weighing 98 to 169 kg at the start of the
study. Each calf was housed individually for 14
days prior to the start of the investigation.
The animals were divided into four groups oftwo
males and two females each. Each group received
daily oral doses of PBB in gelatin capsules, at dose
levels of0.1, 1.0, 10, or 100 mg/kg body weight/day.
These doses are equivalent to about 3.3, 33, 330, or
3300 ppm in the diet.
All calves were weighed each week, and the most
recent weight was used for dose calculations. They
were fed 1 kg of 16% grain ration daily. Hay and
water were allowed ad libitum.
The calves were examined daily for signs ofovert
clinical toxicity.
The following determinations were conducted
upon each calf just prior to the inception of the
study and weekly thereafter: hematocrit, hemoglo-
bin, erythrocyte count, total and differential leuko-
cyte count, mean corpuscular volume, mean cor-
puscular hemoglobin, mean corpuscular hemoglo-
bin concentration, blood urea nitrogen (BUN),
blood glucose, serum alkaline phosphatase (SAP),
serum glutamic-pyruvic transaminase (SGPT), and
serum glutamic-oxalacetic transaminase (SGOT).
One animal (male) from each group was sacrificed
after 2 weeks oftesting, one additional animal from
each group (female) was sacrificed after 4 weeks,
and after 6 weeks a third animal (male) from each
group was sacrificed. The remaining female from
each group was sacrificed after 12 weeks oftesting.
All major tissues and organs were examined grossly
at time of sacrifice. The following tissues and or-
gans were examined histologically: adrenal glands,
brain, pituitary, gonads, heart, kidneys, liver,
lungs, skin, spleen and thyroids.
Samples ofliver, kidney, fat, and skeletal muscle
taken from each animal at sacrifice were analyzed
for BP-6 content.
Cows
Eight Holstein cows were used. Each cow was
individually stanchioned for 14 days prior to the
start of the investigation. All animals were in good
health, mastitis-free, and tested TB- and Brucel-
losis-negative.
They were divided into four groups of two cows
each. Each group received daily oral doses of PBB
in gelatin capsules, equivalent to 0.01, 0.1, 1, or 10
ppm in the diet (based on a daily food consumption
of 17 kg per cow). The total daily food consumption
was 4.5 kg of a 16%o grain ration and approximately
12.5 kg of clover-prairie hay daily; water was per-
mitted ad libitum. The levels were equivalent to
about 0.0003, 0.003, 0.03, or 0.3 m',/kg body weight
per day.
The material was administered for 158 consecu-
tive days to six of eight cows and for 228 consecu-
tive days to the othertwo cows. The lattertwo cows
(No. 2, 0.01 ppm and No. 6, 1 ppm) were pregnant.
Therefore, administration was continued until their
calves were about 2 months old. Administration of
PBB was discontinued and the cows were placed on
recovery for 182 days (6 cows) or 112 days (2 cows).
The total duration ofthe experiment was 340 days.
Total daily milk production was recorded
throughout the investigation. Initial, weekly and
final body weights were recorded throughout the
investigation. Observations for mortality, general
behavorial reactions and pharmacotoxic signs were
conducted daily.
The following determinations were conducted
upon each cow just prior to the inception of the
study and weekly (new calves, too) thereafter,
hematocrit, hemoglobin, erythrocyte count, total
and differential leukocyte counts, mean corpuscular
volume, mean corpuscular hemoglobin, mean cor-
puscular hemoglobin concentration, blood urea ni-
trogen (BUN), blood glucose, serum alkaline phas-
phatase (SAP), serum glutamic-pyruvic trans-
aminase (SGPT), serum glutamic-oxalacetic trans-
aminase (SGOT), albumin, glucose, pH, micro-
scopic examinations leukocyte-erythrocyte.
Thyroid function tests, T-3 or triiodothyronine by
resin uptake, T4 or thyroxine by column and free
thyroid index by calculation, were conducted 3
weeks before the end of the study in the cows.
At the end of the investigation the animals were
sacrificed. All major tissues and organs were
examined grossly during the necropsy. Specimens
ofthe following tissues were preserved in 10% neu-
tral buffered formalin for histological examination:
adrenal gland, brain, bronchial lymph node, gall
bladder, gonads, heart, kidneys, liver, lung, pitui-
tary, spleen, thyroids, and bone with marrow.
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test period, with the collections for the first 90 days
analyzed for BP-6. Weekly milk samples also were
collected and analyzed during the recovery period.
Blood, urine, and feces were collected weekly for
the first 90 days and analyzed for BP-6. Samples of
liver, kidney, fat, skeletal muscle, and bone were
obtained at sacrifice for analysis of BP-6 content.
Extraction and clean-up techniques were de-
veloped and optimized for each type of sample to be
analyzed. Gas-liquid chromatography (Tracor MT-220
gas-chromatograph with a 63Ni detector) was used to
quantitate residues.
The analytical methods for milk, blood, fat, bone
marrow, feces, and urine were validated by
analyzing control tissues fortified at the limit ofsen-
sitivity of each method with BP-6 analytical stan-
dard. The recoveries obtained average 100% for
milk at 1 ppb, 98% for blood at 5 ppb, 100% for fat
and bone marrow at 50 ppb, 76% for feces at 5 ppb,
and 84% for urine at 5 ppb. The highest fortification
level made in fat was at 150 ppm, 93% recovery was
obtained. The precision of analysis of selected tis-
sues was determined by analyzing six aliquots of
each tissue type after homogenization and fortifica-
tion at the limit of sensitivity. Relative standard de-
viations of less than 9% were obtained.
Results
Calves
Generally, poor weight gains or body weight
losses were noted among animals at the 100.0 mg/kg
level. Two calves (male 14 and female 15) lost 8 kg
each, while a third calf (female 16) lost 22 kg. All
calves in the other groups had normal weight gains.
Calves 14 and 16 (100 mg/kg) had decreased food
consumption from test day 36 until sacrifice. There
were no other differences in food consumption val-
ues among calves at any other level.
No deaths occurred. On test day 21, calf 15 (100
mg/kg) became lethargic and remained in this con-
dition until it was sacrificed on day 28. Calves 14
and 16 (both 100 mg/kg) had signs of keratitis, and
lacrimination beginning on day 35 which continued
until time of sacrifice. In addition, on test day 50,
calf 16 developed alopecia and hyperkeratosis in-
volving the head, cervical, and dorsal thoracic re-
gion that progressed in severity until sacrificed.
Although slightly elevated from day 21, the ele-
vated total leukocyte count was apparent on test
days 77 and 84 (weeks 11 and 12) for female 16 at the
100 mg/kg level. Additionally, differential leukocyte
counts revealed a reverse lymphocyte-neutrophil
ratio from day 42 which was especially noticeable
on test day 84, when it was sacrificed. Values for all
other hematologic parameters were essentially the
same among the other groups.
There were increases in SGOT and BUN values
during the final 2 weeks (days 77 and 84) in blood
from the animal (female 16) fed 100 mg/kg. In the
same calf there were decreased SAP values after
day 49. Male 14 (100 mg/kg) also had lower SAP
values on days 35 and 42, at which time he was
sacrificed. Values for all other animals were com-
parable and considered normal among groups for
the clinical chemistry parameters investigated.
The histopathological evaluation ofa series oftis-
sues from the 16 calves revealed treatment-induced
lesions in the kidney, liver, and skin. Lesions were
also observed in the testes which were treatment-
associated and ascribed to several factors including
the nutritional status, age of the animal (prepuberal
development), and duration of exposure to PBB.
One or more of the above tissues were affected in
animals from all test groups. The relative severity of
the treatment-induced lesions was related to dose
level and length of exposure to the test material.
The treatment-related renal lesions comprised a
wide spectrum of degenerative changes which rep-
resent various st-ages in the development of tubular
nephrosis. The most severe lesions were present in
female 16 which was exposed at the highest dose
level (100 mg/kg) for 12 weeks. The renal lesions
observed among animals exposed at the lower test
dose levels for shorter periods oftime were oflesser
severity (minimal) and they consisted of focal dila-
tation of cortical tubules. Some affected tubules
contained exfoliated epithelial lining cells within
their lumen. Among animals at the higher dose
levels or those exposed for a longer period of time,
the tubular dilatation was slightly more severe,
more extensive and was accompanied by regenera-
tion of tubular epithelial cells. Some of the affected
tubules also contained proteinaceous or granular
casts mixed with cellular debris. Lesions of inter-
stitial fibrosis and compression of glomeruli were
also present in the kidney from calf 16.
Treatment-related hepatic lesions were confined
to animals in groups fed 1, 10, or 100 mg/kg. Two
animals (Nos. 6 and 8) at the I mg/kg level that were
exposed to the test material for 6 to 12 weeks, re-
spectively, had foci ofslightly enlarged hepatocytes
located in the centrilobular region of some lobules.
The enlargement of hepatocytes was due to an in-
crease in cytoplasmic mass with no nuclear
changes. However, there was no significant in-
crease in the liver weights of these animals. This
lesion was not evident among animals at other dose
levels. The liver of one female (No. 11) at the 10
mg/kg level and two females (Nos. 14 and 16) at the
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crosis ofindividual or small foci ofhepatocytes with
no lobular distribution. The necrosis ofhepatocytes
was accompanied by liver cell regeneration among
those animals fed 100 mg/kg of PBB.
Treatment-related skin lesions were present
among single female animals at 0.1 mg/kg (No. 4),
10 mg/kg (No. 12), and 100 mg/kg (No. 16) levels
exposed for 12 weeks to PBB. These changes con-
sisted of either acanthosis, hyperkeratosis and/or
dermal infiltrates of mononuclear cells. The
changes were similar in nature among all three ani-
mals but they were most severe in animal No. 16.
Treatment-associated changes were present in
the testes and epididymides of all males in this
study. The changes described as hyposper-
matogenesis of the testes and the absence of sperm
in epididymal ducts are consistent with the age of
these animals due to prepuberal development. De-
generation of the germinal epithelial cells lining
seminiferous tubules was also present in many of
these bull calves. The severity of the degenerative
change was variable but may have resulted from
impairment in the nutritional status ofthese animals
rather than a direct effect of the test material.
Other lesions found were attributed to naturally
occurring diseases or related to the method of sac-
rifice.
Samples of liver, kidney, fat, and muscle ob-
tained from each calf at the time of sacrifice were
analyzed for BP-6 residues. The results of the
analysis are presented in Table 1.
The tissue residue concentrations of BP-6 were
directly related to the dose level and the period of
exposure. The highest levels of BP-6 were found in
the fat. Lower levels were found in kidneys, liver,
and muscle.
Cows
Milk production ranged from 7.6 to 31.4 lb/day
prior to administration of the PBB. The production
in two cows (Nos. 2 and 6) dropped considerably
prior to parturition. After calving, even though ad-
ministration ofPBB continued, their production in-
creased to about 30 lb/day for cow 2 and 50 lb/day
for cow 6. Milk production was decreased in all
cows during the latter part of the recovery period.
This is consistent with the normal state and cycle of
lactation.
The body weights of the cows ranged from 446 to
591 kg at the start of the study. All animals gained
weight during the study. The two pregnant cows
lost weight after delivery, as would be normally ex-
pected after parturition. The two calves weighed 46
and 50 kg, respectively, at birth. They had normal
weight gains and at about 6 months ofage they both
weighed 229 kg.
There were no differences in food consumption
values among cows at any levels. All were consid-
ered normal in this respect.
No deaths occurred during the investigation. The
following reactions were observed. On day 71, cows
2 (0.01 ppm) and 5 and 6 (1 ppm) were stomping
theirfore and hindfeet and appeared uncomfortable.
This lasted until test day 86 for cow 2 and day 75 for
cows 5 and 6. On test day 240, a subcutaneous ac-
cumulation of fluid (about 200 ml) was observed
over the right rib cage of cow 2. The fluid began to
subside on test day 149 and was no longer evident
Table 1. Toxicity and tissue residue study in dairy calves: FireMaster FF-1 residues in tissue.
Dose Time on Time concentration of PBB, ppm
mg/kg body Calf test,
weight/day (number and sex) weeks Muscle Fat Liver Kidney
0.1 1-M 2 0.088 2.56 0.475 0.091
2-M 6 0.119 7.50 0.809 0.419
3-F 4 0.038 7.31 1.43 0.418
4-F 12 0.059 15.8 1.48 0.751
1.0 5-M 2 0.049 18.8 1.21 2.10
6-M 6 0.250 42.5 1.54 2.92
7-F 4 0.244 27.5 1.54 0.987
8-F 12 0.450 58.8 2.61 2.47
10.0 9-M 2 0.694 104.4 2.63 11.8
10-M 6 1.39 241.9 4.13 20.9
11-F 4 1.26 378.0 4.63 20.8
12-F 12 1.84 810.0 6.88 23.3
100.0 13-M 2 15.5 1,010 75.9 90
14-M 6 33.8 6,080 106 201
15-F 4 32.1 4,050 135 203
16-F 12 33.8 6,330 550 683
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growth of the hooves involving all feet which in-
creased in severity for the remainder ofthe investi-
gation.
Hematologic data revealed no treatment-related
changes among any of the parameter investigated.
Cow 6 had an elevated total leukocyte count
throughout the study with lymphocytes comprising
a high percentage of the cells.
Clinical chemistry values were normal and re-
flected no changes related to treatment in any ofthe
cows or in the two calves. The values obtained for
thyroid function were considered to be normal for
cattle of this age. These values compare favorably
with those reported for Holstein cows in another
study (3).
The results ofthe analyses for residues ofBP-6 in
milk are presented in Tables 2 and 3. The residues
increased as the dose increased (0.01 ppm through
10 ppm in the diet). In general, the levels plateaued
after about 4 to 6 weeks and did not go appreciably
higher even though administration of the Fire-
Master FF-l was continued.
Maximum levels ofBP-6 found in milk in relation
to levels in the diet were about 0.06, 0.07, 0.03, and
3 ppm at 0.01, 0.10, 1.0, and 10 ppm in the diet,
respectively. After administration of FireMaster
FF-I was stopped, the levels of BP-6 in milk were
observed to decrease rather slowly. Some BP-6 was
still detectable in milk from animals of all groups
afterthe recovery period (approximately 6 months).
In most cases BP-6 was not detected in urine
(limit of detection 0.005 ppm) after 90 days of ad-
ministration, even at 10 ppm of PBB in the diet.
BP-6 was barely detectable in feces from some
cows fed 0.01 ppm. Levels in feces in cows at other
dose levels were about 0.02, 0.15 or 1.5 ppm at 0.1,
1.0 or 10 ppm in the diet, respectively. It appears
that about 15% of the ingested dose is excreted in
the feces.
Residues in blood were detected (lower limit 0.01
ppm) only in cows fed 10 ppm. The levels ofBP-6 in
their blood were in the order of 0.05 to 0.1 ppm.
The residues in bone marrow and fat from three
sites (tail, stomach and brisket) for the cows and
calves at sacrifice are presented in Table 4. The
Table 2. Milk residue study in diary cattle: residue levels of PBB in milk in test period.
Daily Concentration of PBB, ppm
diet
Cow level, Day Day Day Day Day Day Day Day Day Day Day Day Day Day Day Day Day
No. ppm 0 3 7 14 21 28 35 42 49 56 63 70 77 84 91 166 229
1 0.01 0.001 0.002 0.004 0.007 0.005 0.004 0.048 0.067 0.052 0.027 0.030 0.023 0.021 0.018 0.015 a a
2 0.01 0.001 0.002 0.003 0.004 0.004 0.004 0.045 0.063 0.037 0.022 0.024 0.023 0.026 0.025 0.022 0.011 0.027
3 0.1 0.001 0.004 0.015 0.019 0.025 0.017 0.054 0.048 0.033 0.016 0.035 0.031 0.030 0.030 0.028 a a
4 0.1 0.001 0.010 0.028 0.037 0.039 0.028 0.106 0.058 0.059 0.036 0.049 0.042 0.066 0.049 0.048 a a
5 1.0 0.001 0.260 0.260 0.265 0.269 0.219 0.226 0.270 0.299 0.280 0.315 0.393 0.265 0.342 0.278 a a
6 1.0 0.001 0.072 0.192 0.240 0.227 0.196 0.176 0.226 0.275 0.210 0.305 0.239 0.269 0.218 0.205 0.263 0.258
7 10.0 0.001 1.75 1.91 2.18 1.32 2.14 2.29 2.40 2.70 2.44 3.00 2.39 2.78 2.65 2.70 a a
8 10.0 0.001 1.78 1.56 1.80 1.82 2.02 1.44 2.25 2.38 2.02 2.40 2.25 2.00 2.36 2.25 a a
a Samples not taken.
Table 3. Milk residue study in dairy cattle: residue levels of PPB in milk in recovery period.
Daily
Concentration of PBB, ppm
diet Re- Re- Re- Re- Re- Re- Re- Re- Re- Re- Re- Re- Re-
Cow level, covery covery covery covery covery covery covery covery covery covery covery covery covery
No. ppm day 0 day I day 3 day 7 day 14 day 28 day 30 day 60 day 70 day 100 day 112 day 130 day 183
1 0.01 0.030 0.030 0.010 0.010 0.012 0.011 a a 0.009 0.008 a 0.008 0.004
2 0.01 a a a a a a 0.011 0.018 a a 0.015 a a
3 0.1 0.015 0.032 0.010 0.010 0.010 0.018 a a 0.016 0.010 a 0.013 0.010
4 0.1 0.043 0.045 0.028 0.024 0.027 0.020 a a 0.016 0.011 a 0.015 0.009
5 1.0 0.383 0.380 0.224 0.199 0.199 0.158 a a 0.125 0.088 a 0.141 0.071
6 1.0 a a a a a a 0.108 0.065 a a 0.065 a a
7 10.0 2.63 2.85 1.310 1.80 1.93 1.43 a a 1.20 0.868 a 0.587 0.550
8 10.0 1.61 2.21 0.450 0.788 0.917 0.80 a a 0.85 0.682 a 0.527 0.525
a Samples not taken.
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Daily Sacrifice
diet on Concentration ofPBB, ppm
Animal level, recovery
No. ppm day Tail fat Stomach fat Brisket fat Bone marrow
Cow 1 0.01 182 0.244 0.331 0.319 0.519
Cow 2 0.01 112a 0.677 0.680 0.703 0.738
Calf 2b 175c 0.640 0.547 0.787 0.880
Cow 3 0.10 182 0.520 0.477 0.457 0.665
Cow 4 0.10 182 0.443 0.282 0.417 0.681
Cow 5 1.0 182 3.27 3.55 4.51 4.38
Cow 6 1.0 112a 7.50 5.25 6.61 9.00
Calf6b 169b 7.50 4.09 7.13 8.13
Cow 7 10.0 182 32.6 28.1 47.8 36.0
Cow 8 10.0 182 46.1 29.7 44.5 48.1
a Cows that calved remained on treatment unitl their calves were about 2 months old.
b Born to cow with corresponding number.
c Age ofcalf at time of sacrifice.
residue levels, in general, increased as the level of
oral intake increased. The two cows with shorter
(112 days) recovery periods had higher residues
then the other two at the same feeding level with
longer (182 days) recovery periods. Levels in the fat
were on the order of 50 times the levels in the 0.01
ppm diet and 4.4 times the levels in the 0.1, 1.0, and
10 ppm diets.
Gross and histopathological evaluations were
conducted on a series oftissue from the eight cows
and two calves. The lesions described were re-
garded as either those of naturally occurring dis-
eases related to the age ofthe animal or ascribed to
the method of sacrifice. With regard to the latter,
there was focal hemorrhage in the lung and brain.
The findings in the ovaries were indicative of a
normal estrus cycle in the cows.
Discussion and Summary
One of these studies was conducted to evaluate
the potential toxic effects and to determine tissue
residues of BP-6 after oral administration to Hol-
stein dairy calves. Dose levels of 0.1, 1.0, 10.0, or
100.0 mg/kg were administered daily in gelatin cap-
sules to groups of four calves (two males and two
females) for 2 to 12 consecutive weeks. Calves were
sacrificed at 2, 4, 6, and 12 weeks. Animals at the
highest dose level lost weight and displayed
alopecia, keratitis, and lacrimation from test day 35
until their sacrifice. There were increased BUN,
SAP and SGPT values at the highest dose. His-
topathologic examination of organs and tissues re-
vealed treatment-induced lesions in the kidney,
liver and skin which were dose related. Treatment-
associated changes were present in the testes
among all males. Residue analyses ofliver, kidney,
muscle, and fat revealed treatment and time related
increases in the concentrations of PB-6. Higher
concentrations were found in fat than in the other
tissues analyzed, with the lowest concentration
found in muscle.
The second study was conducted to evaluate po-
tential toxicity and to determine milk and tissue
residue levels of BP-6 after oral administration to
Holstein dairy cows. Doses were equivalent to 0.01,
0.1, 1.0, or 10.0 ppm in the diet and were also ad-
ministered in gelatin capsules. The levels were
based on a total daily food consumption of 17 kg per
cow. Test material was administered daily for 158
consecutive days with the exception of two cows
which were pregnant. Those cows received the test
material for an additional 70 days. No effects upon
milk production, body weights, amount of food
consumed, and hematologic clinical chemistry, and
urinalysis studies were noted. No deaths occurred.
Analysis for BP-6 in milk, blood, feces, urine, and
fat revealed a dosage related increase. However,
after approximately 4 to 6 weeks of PBB adminis-
tration the residue levels in milkplateaued and there
appeared to be no further accumulation as the res-
idue levels remained relatively constant. Gross and
histopathologic studies conducted on all cows re-
vealed no treatment-related lesions. Two cows were
pregnant when the study was initiated. These cows
were treated during pregnancy and allowed to
calve. No problems occurred at parturition, and
both calves were normal in appearance and healthy
from birth to sacrifice. Though neither calf was
treated, tissue residue analysis for BP-6 showed its
presence, indicating the passage of the compound
through the placental barrier and/or ingestion
through the milk.
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